QIAGEN Net Profit Margin 2006-2021 | QGEN

Current and historical net profit margin for QIAGEN (QGEN) from 2006 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue. QIAGEN net profit margin for the three months ending September 30, 2021 was .
QIAGEN Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-09-30 $2.24B $0.60B 26.61%
2021-06-30 $2.19B $0.48B 21.93%
2021-03-31 $2.07B $0.45B 21.74%
2020-12-31 $1.87B $0.36B 19.25%
2020-09-30 $1.71B $0.19B 11.21%
2020-06-30 $1.61B $0.01B 0.87%
2020-03-31 $1.55B $-0.03B -2.00%
2019-12-31 $1.53B $-0.04B -2.69%
2019-09-30 $1.52B $-0.03B -1.65%
2019-06-30 $1.51B $0.20B 12.96%
2019-03-31 $1.51B $0.19B 12.48%
2018-12-31 $1.50B $0.19B 12.65%
2018-09-30 $1.50B $0.09B 5.95%
2018-06-30 $1.48B $0.08B 5.20%
2018-03-31 $1.45B $0.05B 3.71%
2017-12-31 $1.42B $0.04B 2.82%
2017-09-30 $1.39B $0.09B 6.41%
2017-06-30 $1.36B $0.08B 5.58%
2017-03-31 $1.35B $0.08B 6.16%
2016-12-31 $1.34B $0.08B 6.05%
2016-09-30 $1.32B $0.12B 9.39%
2016-06-30 $1.30B $0.12B 9.49%
2016-03-31 $1.28B $0.13B 9.91%
2015-12-31 $1.28B $0.13B 10.15%
2015-09-30 $1.29B $0.10B 8.05%
2015-06-30 $1.31B $0.11B 8.00%
2015-03-31 $1.33B $0.11B 8.53%
2014-12-31 $1.34B $0.12B 8.71%
2014-09-30 $1.35B $0.15B 11.23%
2014-06-30 $1.33B $0.16B 11.80%
2014-03-31 $1.32B $0.07B 5.48%
2013-12-31 $1.30B $0.07B 5.30%
2013-09-30 $1.29B $0.05B 3.65%
2013-06-30 $1.27B $0.04B 2.76%
2013-03-31 $1.26B $0.12B 9.51%
2012-12-31 $1.25B $0.13B 10.29%
2012-09-30 $1.24B $0.09B 7.33%
2012-06-30 $1.23B $0.10B 7.91%
2012-03-31 $1.20B $0.10B 8.08%
2011-12-31 $1.17B $0.10B 8.21%
2011-09-30 $1.12B $0.13B 11.78%
2011-06-30 $1.11B $0.13B 12.03%
2011-03-31 $1.09B $0.14B 12.79%
2010-12-31 $1.09B $0.14B 13.25%
2010-09-30 $1.09B $0.15B 13.94%
2010-06-30 $1.08B $0.15B 14.31%
2010-03-31 $1.05B $0.15B 13.87%
2009-12-31 $1.01B $0.14B 13.66%
2009-09-30 $0.96B $0.12B 12.42%
2009-06-30 $0.93B $0.10B 10.98%
2009-03-31 $0.91B $0.09B 10.36%
2008-12-31 $0.89B $0.09B 9.97%
2008-09-30 $0.87B $0.08B 9.12%
2008-06-30 $0.81B $0.05B 6.28%
2008-03-31 $0.73B $0.05B 7.00%
2007-12-31 $0.65B $0.05B 7.85%
2007-09-30 $0.57B $0.06B 9.72%
2007-06-30 $0.51B $0.08B 15.98%
2007-03-31 $0.49B $0.07B 14.85%
2006-12-31 $0.47B $0.07B 15.02%
2006-09-30 $0.44B $0.07B 15.32%
2006-06-30 $0.43B $0.07B 15.76%
2006-03-31 $0.41B $0.07B 16.26%
2005-12-31 $0.40B $0.06B 15.83%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.791B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88